Trial Profile
Macugen for Histoplasmosis-An Open-Label, Single-Site, Comparative, Prospective Case Series
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 22 Jun 2014
Price :
$35
*
At a glance
- Drugs Pegaptanib (Primary) ; Verteporfin
- Indications Choroidal neovascularisation; Histoplasmosis
- Focus Therapeutic Use
- 22 Jun 2014 New trial record
- 26 Oct 2006
- 15 Feb 2006